Biotech · Public company · Winston-Salem, NC, US
Prokidney Corp.
Ticker PROK · SEC CIK 0001850270
Track this companyFree. Adds Prokidney Corp. to your Dealase workspace and tells you when its record changes.
Clinical trials93 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline8
- Renal Autologous Cell Therapy (REACT/ rilparencel)Phase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Sham ComparatorPhase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Neo-Kidney AugmentPhase 2 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Renal Autologous Cell Therapy (REACT)Phase 2 · Chronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- Renal Autologous Cell Therapy (REACT)Phase 2 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Renal BiopsyPhase 2 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Renal Autologous Cell Therapy (REACT)Phase 1 · Diabetic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Renal Autologous Cell Therapy (REACT)Phase 1 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Long-Term Follow-Up Study of Participants Exposed to REACTRECRUITING · started Dec 11, 2023ClinicalTrials.gov NCT05918523 · fetched Nov 12, 2026
- Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen ProductENROLLING_BY_INVITATION · started Nov 23, 2023ClinicalTrials.gov NCT06790498 · fetched Nov 12, 2026
- A Study of Participants With Chronic Kidney Disease Previously Treated With REACTPHASE1 · TERMINATED · started Jul 11, 2023ClinicalTrials.gov NCT05694169 · fetched Nov 12, 2026
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseasePHASE3 · ACTIVE_NOT_RECRUITING · started Jan 5, 2022ClinicalTrials.gov NCT05099770 · fetched Nov 12, 2026
- Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)PHASE2 · COMPLETED · started Jul 27, 2021ClinicalTrials.gov NCT05018416 · fetched Nov 12, 2026
- A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).PHASE1 · COMPLETED · started Aug 13, 2019ClinicalTrials.gov NCT04115345 · fetched Nov 12, 2026
- A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney DiseasePHASE2 · COMPLETED · started Apr 25, 2018ClinicalTrials.gov NCT03270956 · fetched Nov 12, 2026
- A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney DiseasePHASE2 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02836574 · fetched Nov 12, 2026
- Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)PHASE2 · TERMINATED · started Jul 1, 2016ClinicalTrials.gov NCT02525263 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 18, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 18, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2025 · fetched Nov 12, 2026